In 2020, the population of Peru was approximately 33 million people. In that same year, an estimated 38,000 people developed TB. Among them, 2,600 were children. Moreover, there were 14,250 missing people with TB (1,667 were children).
In 2018, Delft Imaging started collaborating with Socios en Salud as part of the ZeroTB initiative, intending to screen 100,000 people in Peru using CAD4TB. CAD4TB is the software that uses artificial intelligence to detect TB-related abnormalities in a chest X-ray automatically.
In 2019, Socios en Salud procured the CAD4TB artificial intelligence solution for another two sites to support TB screening efforts.
In 2021, Socios en Salud procured CAD4TB for another 11 sites, intending to screen another 130,000 people. Later that same year, another 50,000 additional people were screened.
In 2023, another site supported by Socios en Salud received access to CAD4TB.
Making a difference
A 2022 study examined integrated screening and testing for TB and COVID-19 in Peru. The study used CAD4TB and showed that integrated screening can help avoid delays in diagnosing TB and COVID-19.
Socios En Salud, supported by Peru’s Ministry of Health and Esperanza Amazonica Medical Program, conducted free TB screenings in the remote communities of Loreto, Peru. Operating aboard a boat, the active case-finding used CAD4TB to rapidly identify TB cases and ensure timely intervention, in the heart of peruvian jungle. Read more about it here.
In 2024, ERUINPE and MINSA commemorated World TB Day with a TB screening campaign at Lurigancho prison using CAD4TB. Read more about the event here.
Celebrating World TB Day 2024, PAHO TV featured a video highlighting CAD4TB and Delft Light.
Case Study
Discover how innovative strategies like urban mobile brigades and portable X-ray machines with CAD4TB AI software are making significant strides in TB diagnosis among Lima’s transgender community, a group facing unique health challenges. Read more through the case study “Active TB Case-finding in Transgender Populations.”
